drugset
drugset / Trial / NCT06354998

A Study of an Investigational mRNA-1273.815 COVID-19 Vaccine in Previously Vaccinated Adults

NCT06354998 ↗

Phase 3 Completed 217 enrolled ModernaTX, Inc.
RandomizedParallel-groupQuadruple-blindPrevention

Summary

To evaluate immune responses of an Investigational mRNA-1273.815 vaccine against the Omicron subvariant strain (XBB.1.5) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Timeline

Start
2024-04-08
Primary completion
2024-05-10
Completion
2024-05-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Elasomeran Messenger RNA (mRNA) — Intramuscular
Subject mRNA-1273.815 Messenger RNA (mRNA) — Intramuscular

Indications

Orthocoronavirinae infectious disease